Related Experiment Videos
In situ or localized breast cancer--how much treatment is needed?
The New England Journal of Medicine
|June 3, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC).
Annals of oncology : official journal of the European Society for Medical Oncology·2024
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Tozorakimab to Prevent COPD Exacerbations.
The New England journal of medicine·2026